Alaunos Therapeutics Inc (STU:WEK)
€ 1.66 0 (-4.82%) Market Cap: 338.23 Mil Enterprise Value: 276.94 Mil PE Ratio: 0 PB Ratio: 1.04 GF Score: 54/100

Q4 2020 ZIOPHARM Oncology Inc Earnings Call Transcript

Feb 25, 2021 / 09:30PM GMT
Release Date Price: €3.8 (-3.55%)
Operator

Greetings, and welcome to Ziopharm Oncology, Inc. Fourth Quarter and Fiscal Year 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Adam Levy, Executive Vice President of Investor Relations and Corporate Communications. Please go ahead.

Adam D. Levy
ZIOPHARM Oncology, Inc. - EVP of IR & Corporate Communications

Thank you, Omar. Good afternoon, and welcome to the Ziopharm Oncology Conference call and webcast to review results for the fourth quarter and year ended December 31, 2020. This afternoon, we issued our financial press release, which is also available in the Investors section of our website, ziopharm.com.

For informational purposes, we have also included in our webcast a set of slides to accompany today's commentary. These slides can also be found on our website. Today's press release also contains several other corporate updates which will be discussed by our speakers.

During today's call, the company will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot